Startups set off new wave of mRNA therapeutics
Elie Dolgin • September 2, 2021
After the vaccine triumphs of Pfizer/BioNTech and Moderna, a raft of startups is developing mRNA, circular RNA and self-amplifying RNA therapeutics.
A cadre of new startups are building next-generation RNA platform technologies designed to solve some of the unique challenges associated with using conventional mRNA tools as therapeutics.
Read more at Nature Biotechnology.
In January 2025, Linda-Gail Bekker stood inside a vaccine manufacturing plant and allowed herself to believe that the first HIV vaccine candidate conceived through African science and led by Africans might finally become a reality. Continue reading at V ox .
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.